Global Non-Opioid Patch 麻豆原创 Research Report 2023

Publication ID:

PB504245020

Publication Date:

May 22, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global Non-Opioid Patch market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Non-Opioid Patch is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Non-Opioid Patch is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Non-Opioid Patch include NEXGEL Advanced Hydrogel Solutions, Viatris Inc., Johnson and Johnson, Teva Pharmaceutical Industries Ltd, Sorrento Therapeutics Inc., Hisamitsu Pharmaceutical Co.,Inc., Endo International plc., Purdue Pharma L.P. and Amneal Pharmaceuticals LLC, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Non-Opioid Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Opioid Patch.
The Non-Opioid Patch market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Non-Opioid Patch market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-Opioid Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
NEXGEL Advanced Hydrogel Solutions
Viatris Inc.
Johnson and Johnson
Teva Pharmaceutical Industries Ltd
Sorrento Therapeutics Inc.
Hisamitsu Pharmaceutical Co.,Inc.
Endo International plc.
Purdue Pharma L.P.
Amneal Pharmaceuticals LLC
Grunenthal
Segment by Type
Prescription Medicines
OTC Medicines
Segment by Application
Hospital Pharmacies
Drug Stores
Online Pharmacies
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-Opioid Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-Opioid Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Non-Opioid Patch 麻豆原创 Overview
1.1 Product Overview and Scope of Non-Opioid Patch
1.2 Non-Opioid Patch Segment by Type
1.2.1 Global Non-Opioid Patch 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 Prescription Medicines
1.2.3 OTC Medicines
1.3 Non-Opioid Patch Segment by Application
1.3.1 Global Non-Opioid Patch 麻豆原创 Value by Application: (2023-2029)
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Online Pharmacies
1.4 Global Non-Opioid Patch 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Non-Opioid Patch Revenue 2018-2029
1.4.2 Global Non-Opioid Patch Sales 2018-2029
1.4.3 Global Non-Opioid Patch 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Non-Opioid Patch 麻豆原创 Competition by Manufacturers
2.1 Global Non-Opioid Patch Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Non-Opioid Patch Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Non-Opioid Patch Average Price by Manufacturers (2018-2023)
2.4 Global Non-Opioid Patch Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Non-Opioid Patch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-Opioid Patch, Product Type & Application
2.7 Non-Opioid Patch 麻豆原创 Competitive Situation and Trends
2.7.1 Non-Opioid Patch 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-Opioid Patch Players 麻豆原创 Share by Revenue
2.7.3 Global Non-Opioid Patch 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-Opioid Patch Retrospective 麻豆原创 Scenario by Region
3.1 Global Non-Opioid Patch 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Non-Opioid Patch Global Non-Opioid Patch Sales by Region: 2018-2029
3.2.1 Global Non-Opioid Patch Sales by Region: 2018-2023
3.2.2 Global Non-Opioid Patch Sales by Region: 2024-2029
3.3 Global Non-Opioid Patch Global Non-Opioid Patch Revenue by Region: 2018-2029
3.3.1 Global Non-Opioid Patch Revenue by Region: 2018-2023
3.3.2 Global Non-Opioid Patch Revenue by Region: 2024-2029
3.4 North America Non-Opioid Patch 麻豆原创 Facts & Figures by Country
3.4.1 North America Non-Opioid Patch 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Non-Opioid Patch Sales by Country (2018-2029)
3.4.3 North America Non-Opioid Patch Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-Opioid Patch 麻豆原创 Facts & Figures by Country
3.5.1 Europe Non-Opioid Patch 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Non-Opioid Patch Sales by Country (2018-2029)
3.5.3 Europe Non-Opioid Patch Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-Opioid Patch 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Non-Opioid Patch 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Non-Opioid Patch Sales by Country (2018-2029)
3.6.3 Asia Pacific Non-Opioid Patch Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Non-Opioid Patch 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Non-Opioid Patch 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Non-Opioid Patch Sales by Country (2018-2029)
3.7.3 Latin America Non-Opioid Patch Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-Opioid Patch 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Non-Opioid Patch 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Non-Opioid Patch Sales by Country (2018-2029)
3.8.3 Middle East and Africa Non-Opioid Patch Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-Opioid Patch Sales by Type (2018-2029)
4.1.1 Global Non-Opioid Patch Sales by Type (2018-2023)
4.1.2 Global Non-Opioid Patch Sales by Type (2024-2029)
4.1.3 Global Non-Opioid Patch Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Non-Opioid Patch Revenue by Type (2018-2029)
4.2.1 Global Non-Opioid Patch Revenue by Type (2018-2023)
4.2.2 Global Non-Opioid Patch Revenue by Type (2024-2029)
4.2.3 Global Non-Opioid Patch Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Non-Opioid Patch Price by Type (2018-2029)
5 Segment by Application
5.1 Global Non-Opioid Patch Sales by Application (2018-2029)
5.1.1 Global Non-Opioid Patch Sales by Application (2018-2023)
5.1.2 Global Non-Opioid Patch Sales by Application (2024-2029)
5.1.3 Global Non-Opioid Patch Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Non-Opioid Patch Revenue by Application (2018-2029)
5.2.1 Global Non-Opioid Patch Revenue by Application (2018-2023)
5.2.2 Global Non-Opioid Patch Revenue by Application (2024-2029)
5.2.3 Global Non-Opioid Patch Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Non-Opioid Patch Price by Application (2018-2029)
6 Key Companies Profiled
6.1 NEXGEL Advanced Hydrogel Solutions
6.1.1 NEXGEL Advanced Hydrogel Solutions Corporation Information
6.1.2 NEXGEL Advanced Hydrogel Solutions Description and Business Overview
6.1.3 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.1.4 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product Portfolio
6.1.5 NEXGEL Advanced Hydrogel Solutions Recent Developments/Updates
6.2 Viatris Inc.
6.2.1 Viatris Inc. Corporation Information
6.2.2 Viatris Inc. Description and Business Overview
6.2.3 Viatris Inc. Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Viatris Inc. Non-Opioid Patch Product Portfolio
6.2.5 Viatris Inc. Recent Developments/Updates
6.3 Johnson and Johnson
6.3.1 Johnson and Johnson Corporation Information
6.3.2 Johnson and Johnson Description and Business Overview
6.3.3 Johnson and Johnson Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Johnson and Johnson Non-Opioid Patch Product Portfolio
6.3.5 Johnson and Johnson Recent Developments/Updates
6.4 Teva Pharmaceutical Industries Ltd
6.4.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.4.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.4.3 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product Portfolio
6.4.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.5 Sorrento Therapeutics Inc.
6.5.1 Sorrento Therapeutics Inc. Corporation Information
6.5.2 Sorrento Therapeutics Inc. Description and Business Overview
6.5.3 Sorrento Therapeutics Inc. Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Sorrento Therapeutics Inc. Non-Opioid Patch Product Portfolio
6.5.5 Sorrento Therapeutics Inc. Recent Developments/Updates
6.6 Hisamitsu Pharmaceutical Co.,Inc.
6.6.1 Hisamitsu Pharmaceutical Co.,Inc. Corporation Information
6.6.2 Hisamitsu Pharmaceutical Co.,Inc. Description and Business Overview
6.6.3 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product Portfolio
6.6.5 Hisamitsu Pharmaceutical Co.,Inc. Recent Developments/Updates
6.7 Endo International plc.
6.6.1 Endo International plc. Corporation Information
6.6.2 Endo International plc. Description and Business Overview
6.6.3 Endo International plc. Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Endo International plc. Non-Opioid Patch Product Portfolio
6.7.5 Endo International plc. Recent Developments/Updates
6.8 Purdue Pharma L.P.
6.8.1 Purdue Pharma L.P. Corporation Information
6.8.2 Purdue Pharma L.P. Description and Business Overview
6.8.3 Purdue Pharma L.P. Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Purdue Pharma L.P. Non-Opioid Patch Product Portfolio
6.8.5 Purdue Pharma L.P. Recent Developments/Updates
6.9 Amneal Pharmaceuticals LLC
6.9.1 Amneal Pharmaceuticals LLC Corporation Information
6.9.2 Amneal Pharmaceuticals LLC Description and Business Overview
6.9.3 Amneal Pharmaceuticals LLC Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Amneal Pharmaceuticals LLC Non-Opioid Patch Product Portfolio
6.9.5 Amneal Pharmaceuticals LLC Recent Developments/Updates
6.10 Grunenthal
6.10.1 Grunenthal Corporation Information
6.10.2 Grunenthal Description and Business Overview
6.10.3 Grunenthal Non-Opioid Patch Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Grunenthal Non-Opioid Patch Product Portfolio
6.10.5 Grunenthal Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-Opioid Patch Industry Chain Analysis
7.2 Non-Opioid Patch Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-Opioid Patch Production Mode & Process
7.4 Non-Opioid Patch Sales and 麻豆原创ing
7.4.1 Non-Opioid Patch Sales Channels
7.4.2 Non-Opioid Patch Distributors
7.5 Non-Opioid Patch Customers
8 Non-Opioid Patch 麻豆原创 Dynamics
8.1 Non-Opioid Patch Industry Trends
8.2 Non-Opioid Patch 麻豆原创 Drivers
8.3 Non-Opioid Patch 麻豆原创 Challenges
8.4 Non-Opioid Patch 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

NEXGEL Advanced Hydrogel Solutions
Viatris Inc.
Johnson and Johnson
Teva Pharmaceutical Industries Ltd
Sorrento Therapeutics Inc.
Hisamitsu Pharmaceutical Co.,Inc.
Endo International plc.
Purdue Pharma L.P.
Amneal Pharmaceuticals LLC
Grunenthal

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.